Age, Biography and Wiki

Andreas Strüngmann was born on 1950 in Germany, is an Entrepreneur. Discover Andreas Strüngmann's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is He in this year and how He spends money? Also learn how He earned most of networth at the age of 73 years old?

Popular As N/A
Occupation Entrepreneur
Age N/A
Zodiac Sign
Born 1950, 1950
Birthday 1950
Birthplace N/A
Nationality Germany

We recommend you to check the complete list of Famous People born on 1950. He is a member of famous Entrepreneur with the age years old group.

Andreas Strüngmann Height, Weight & Measurements

At years old, Andreas Strüngmann height not available right now. We will update Andreas Strüngmann's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.

Physical Status
Height Not Available
Weight Not Available
Body Measurements Not Available
Eye Color Not Available
Hair Color Not Available

Dating & Relationship status

He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.

Family
Parents Not Available
Wife Not Available
Sibling Not Available
Children Not Available

Andreas Strüngmann Net Worth

His net worth has been growing significantly in 2022-2023. So, how much is Andreas Strüngmann worth at the age of years old? Andreas Strüngmann’s income source is mostly from being a successful Entrepreneur. He is from Germany. We have estimated Andreas Strüngmann's net worth , money, salary, income, and assets.

Net Worth in 2023 $1 Million - $5 Million
Salary in 2023 Under Review
Net Worth in 2022 Pending
Salary in 2022 Under Review
House Not Available
Cars Not Available
Source of Income Entrepreneur

Andreas Strüngmann Social Network

Instagram
Linkedin
Twitter
Facebook
Wikipedia
Imdb

Timeline

1950

Andreas Strüngmann (born 1950) is a German businessman and founded generic drug maker Hexal AG ($1.6 billion sales during 2004) in 1986. It became Germany's second-largest generic drug producer. In February 2005, he and his brother Thomas sold Hexal and their 67.7% of U.S. Eon Labs to Novartis for $7.5 billion, making its subsidiary Sandoz the largest generic-drug company in the world.